2021 marks a new era for Alzheimer's therapeutics
Author:
Funder
National Institutes of Health
Alzheimer's Drug Discovery Foundation
Publisher
Elsevier BV
Subject
Neurology (clinical)
Reference9 articles.
1. Aducanumab: appropriate use recommendations;Cummings;J Prev Alzheimers Dis,2021
2. Donanemab in early Alzheimer's disease;Mintun;N Engl J Med,2021
3. ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease;Novak;Nature Aging,2021
4. NIA-AA Research Framework: toward a biological definition of Alzheimer's disease;Jack;Alzheimers Dement,2018
5. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study;Thijssen;Lancet Neurol,2021
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of Neurodegenerative Disorders with Amyloid-β, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls;Journal of Nuclear Medicine;2024-04-25
2. Effect of Regulation of Chemerin/Chemokine-like Receptor 1/Stimulator of Interferon Genes Pathway on Astrocyte Recruitment to Aβ Plaques;International Journal of Molecular Sciences;2024-04-13
3. Urine biomarkers for Alzheimer's disease: A new opportunity for wastewater-based epidemiology?;Environment International;2024-02
4. Prevention of Alzheimer Pathology by Blocking Neuregulin Signaling on Microglia;eneuro;2023-10-30
5. Health economic analysis of the integrated cognitive assessment tool to aid dementia diagnosis in the United Kingdom;Frontiers in Public Health;2023-09-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3